Raghunandan Avula

Articles

• Ebola outbreak leads to new drug development initiatives

  The whole world has been gripped by the recent Ebola virus outbreak, with multiple countries attempting to establish effective practices to prevent the spread of the pathogen. In addition to the active battle against the virus, there is a newfound interest in fully understanding the virus to determine why it is so pernicious.

  SciTech | October 27, 2014
• CNAST receives gift

  Carnegie Mellon’s Center for Nucleic Acids Science and Technology (CNAST) brings together researchers to form a multidisciplinary approach for developing synthetic nucleic acids that have the potential to aid in the diagnosis and treatment of various diseases. Recently, the center received a gift from the DSF Charitable Foundation for $3.1 million.

  SciTech | September 29, 2014
• How Things Work: Neuroscience studies explain why humans experience empathy

  Like everything in our universe, humans are fundamentally a collection of molecules interacting with each other. Unlike anything else in our universe, however, humans share a unique ability to fully experience the world around them, largely because of our neurological complexity.

  SciTech | August 25, 2014
• New method analyzes how drugs affect gene networks

  Modern drug development is a lengthy, lavish, and laborious process largely because biological systems are complex and dynamic.

  SciTech | August 15, 2014
• Sailfish allows for faster gene studies

  A single cell is home to an unfathomable number of molecular interactions. Over one trillion cells work together perfectly to produce a well-oiled machine: the human body. Scientists, however, are fascinated with how the smallest deviation from the norm within a cell can have catastrophic consequences.

  SciTech | April 28, 2014